Presentation Information

[P-34]日本における乳児のRSウイルス感染症予防戦略の費用対効果

*kazumasa kamei1, Yoko Hirano1, Yoshikazu Nakayama1, Amy W Law2 (1. Pfizer Japan Inc., 2. Pfizer Inc.)

Password required to view